Mirum Pharmaceuticals
MIRM
80.64
+1.39
+1.75%
Mirum Pharmaceuticals
US · MIRM
#2051 by market cap
Listed 2019
80.64
+1.39
+1.75%
Live - 5344 symbols - heartbeat 397s ago
· 2026-10-07 19:54
After-hours
80.64
0.00%
- Market cap
- 5.24B
- P/E (TTM)i
- -5.73
- P/Bi
- -500.87
- EPSi
- -0.47
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on MIRM?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 11 analysts
Buy
Avg price target
146.40 +81.5%
Price target rangecurrent 80.64
Low130.00
Avg146.40
High195.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | Baird | -- | BUY | 130.00 |
| 2026-09-29 | Citi | -- | BUY | 160.00 |
| 2026-09-29 | H.C. Wainwright | -- | BUY | 195.00 |
| 2026-09-28 | TD Cowen | -- | BUY | 140.00 |
| 2026-09-28 | Morgan Stanley | -- | BUY | 137.00 |
| 2026-09-28 | Citi | -- | BUY | 160.00 |
| 2026-09-28 | Leerink Partners | -- | BUY | 154.00 |
| 2026-09-28 | H.C. Wainwright | -- | BUY | 195.00 |
| 2026-09-28 | J.P. Morgan | -- | BUY | -- |
| 2026-09-10 | Citi | -- | BUY | 145.00 |
| 2026-08-21 | H.C. Wainwright | -- | BUY | 140.00 |
| 2026-08-20 | H.C. Wainwright | -- | BUY | 140.00 |
| 2026-08-11 | J.P. Morgan | -- | BUY | 118.00 |
| 2026-08-10 | TD Cowen | -- | BUY | 140.00 |
| 2026-08-09 | TD Cowen | -- | BUY | 140.00 |
| 2026-08-06 | Baird | -- | BUY | 123.00 |
| 2026-08-06 | Citizens JMP | -- | BUY | 137.00 |
| 2026-08-06 | Morgan Stanley | -- | BUY | 137.00 |
| 2026-08-06 | Stifel | -- | BUY | 136.00 |
| 2026-08-06 | H.C. Wainwright | -- | BUY | 140.00 |
| 2026-08-06 | RBC Capital | -- | BUY | 135.00 |
| 2026-08-06 | J.P. Morgan | -- | BUY | 118.00 |
| 2026-08-05 | TD Cowen | -- | BUY | 140.00 |
| 2026-08-05 | Cantor Fitzgerald | -- | BUY | 140.00 |
| 2026-08-03 | H.C. Wainwright | -- | BUY | 185.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | After close | ±9.27% | -11.04% (beat) |
| 2026/Q1 | 2026-05-06 | After close | ±6.10% | -6.50% (beat) |
| 2025/Q4 | 2026-02-25 | After close | ±8.08% | -15.13% (beat) |
| 2025/Q3 | 2025-11-04 | After close | ±9.62% | -1.24% (in line) |
| 2025/Q2 | 2025-08-06 | After close | ±9.40% | +12.04% (beat) |
| 2025/Q1 | 2025-05-07 | After close | ±8.61% | +9.75% (beat) |
| 2024/Q4 | 2025-02-26 | After close | ±12.69% | -7.02% (in line) |
| 2024/Q3 | 2024-11-12 | -- | -- | +1.61% |
| 2024/Q2 | 2024-08-07 | After close | ±14.68% | +2.34% (in line) |
| 2024/Q1 | 2024-05-08 | After close | ±8.59% | +3.16% (in line) |
| 2023/Q4 | 2024-02-28 | After close | ±20.04% | -0.62% (in line) |
| 2023/Q3 | 2023-11-02 | After close | ±18.69% | +5.67% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.